Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. (Q37966305)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

meta-analysis

0 references

title

Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Heikki Joensuu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Aki Vehtari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Chiara Braconi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Massimo Federico

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Massimo Federico

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Piotr Rutkowski

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

4

Toshirou Nishida

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Jaakko Riihimäki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sonja E Steigen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Peter Brabec

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Lukas Plank

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Bengt Nilsson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Claudia Cirilli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Andrea Bordoni

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Magnus K Magnusson

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Zdenek Linke

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jozef Sufliarsky

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jon G Jonasson

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

6 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

265-274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

High incidence of microscopic gastrointestinal stromal tumors in the stomach.

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Gastrointestinal stromal tumour.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Gastrointestinal stromal tumors: pathology and prognosis at different sites

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Diagnosis of gastrointestinal stromal tumors: A consensus approach

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Risk stratification of patients diagnosed with gastrointestinal stromal tumor.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Gastrointestinal stromal tumors in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Mutations in gastrointestinal stromal tumors--a population-based study from Northern Norway

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

A whole population study of gastrointestinal stromal tumors in the Czech Republic and Slovakia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Gastrointestinal stromal tumours (GIST) - 17 years experience from Mid Trent Region (United Kingdom).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

Bayesian model assessment and comparison using cross-validation predictive densities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

An improved technique for mitosis counting

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970299-6

7 January 2021

10.1016/S1470-2045(11)70299-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153892%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference